Metformin use lowers risk of neurodegenerative diseases in diabetes patients
A recent meta-analysis showed that metformin use, especially long-term use is tied to a lower risk of neurodegenerative disease (ND) in diabetes patients. However, the researchers add, "owing to a substantial heterogeneity among studies, there is a need for high-quality randomized controlled trials to confirm the finding."
There has always been a controversy on the association between metformin use and neurodegenerative disease onset. To clarify the same, Zubing Mei, Anorectal Disease Institute of Shuguang Hospital, Shanghai, China, and colleagues aimed to determine the relationship between metformin use and ND risk based on data from population-based cohort studies in a systematic review and meta-analysis published in the journal Diabetic Medicine.
For more information check out the full story on the link below:
Metformin use lowers risk of neurodegenerative diseases in diabetes patients
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.